This article was originally published in The Gray Sheet
Agency should consider buying direct-to-consumer ads, similar to those from CMS on nursing home quality, to educate the public about risks associated with popular devices, procedures and drugs, CMS Administrator Tom Scully tells the HHS Regulatory Reform Committee June 10 in Minneapolis. CDRH director David Feigal agrees: "One of the responsibilities we need to take on as a health community...is risk communication," he says...
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.